Ayan Das Gupta

Continuous, Automated Breathing Rate and Body Motion Monitoring of Rats With Paraquat-Induced Progressive Lung Injury

D. Rowlands, S. Baran, L. Schaevitz, 2020, Frontiers in Physiology.

OP0235 SECUKINUMAB IMPROVES AXIAL MANIFESTATIONS IN PATIENTS WITH PSORIATIC ARTHRITIS AND INADEQUATE RESPONSE TO NSAIDS: PRIMARY ANALYSIS OF THE MAXIMISE TRIAL

L. Coates, L. Gossec, X. Baraliakos, 2019, Oral Presentations.

Secukinumab Efficacy on Enthesitis in Patients With Ankylosing Spondylitis: Pooled Analysis of Four Pivotal Phase III Studies

A. Deodhar, L. Gensler, A. Winseck, 2021, The Journal of Rheumatology.

COVID-19 Outcomes and Vaccination in People with Relapsing Multiple Sclerosis Treated with Ofatumumab

X. Montalban, A. Cross, B. Ward, 2022, Neurology and Therapy.

Compliance and Persistence With Ofatumumab Treatment in Patients With Relapsing Multiple Sclerosis in Clinical Trials for Up to 4 Years (P8-3.002)

E. Alvarez, R. Zielman, Xixi Hu, 2023, Tuesday, April 25.